Hapvida Participacoes e Investimentos stock
Price history
−64.48% over the period1 year: from R$17.34 (November 19, 2025) to R$6.16 (November 19, 2026), −64.48%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 19, 2026 | R$6.16 |
| October 30, 2026 | R$4.20 |
| September 30, 2026 | R$6.67 |
| August 31, 2026 | R$6.61 |
| July 31, 2026 | R$11.28 |
| June 30, 2026 | R$10.21 |
| May 29, 2026 | R$12.15 |
| April 30, 2026 | R$12.39 |
| March 31, 2026 | R$10.10 |
| February 27, 2026 | R$10.49 |
| January 30, 2026 | R$13.00 |
| December 30, 2025 | R$14.73 |
| November 28, 2025 | R$14.10 |
| November 19, 2025 | R$17.34 |
At a glance
The company
Operates a health insurance business with integrated clinical, outpatient and hospital networks, plus dental plans in Brazil
Latest results
Quarter to September 30, 2026 · EPS -R$0.01 (estimate R$0.04)
TickerLandia's take on Hapvida Participacoes e Investimentos
- Strong point: Growth (56/100 in its group). Weak point: Market momentum (11/100).
- “Value traps” (Brazil): No. 3 of 7.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−67.70% from the 52-week high
Analysts · 12 analysts
Average targetR$10.34+67.83% vs. price
Buy 0 · Hold 12 · Sell 0 · Hold
TickerLandia Fingerprint: Hapvida Participacoes e Investimentos
Compared with similar companies: very high risk, very low price, and very weak momentum.
Financials and price compared with 32 companies in the insurance - life industry, worldwide. Momentum and risk compared with 317 Latin American stocks.
Pricevery low5
How much it costs relative to what it produces.
Metric Value Position in group Price/sales 0.08 5 Price/book 0.06 2 Forward P/E 4.61 8 Profitabilitylow23
How much it earns on revenue and capital.
Metric Value Position in group ROA 1.5% 70 Operating margin 5.7% 14 Net margin −0.5% 5 ROE −0.4% 5 Earnings stabilityvery low18
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 4.9% 33 Loss-making yearscounts in reverse: lower means more earnings stability 4 of 5 annual reports 3 Growthaverage56
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) −75.76% 16 Revenue growth (year over year) +41.30% 89 Average revenue growth (3 years) +9.87% 63 Financial strengthdoes not apply to banks and insurers
How well it would weather a hard period: debt, liquidity, interest.
Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumvery weak11
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −5.28% 34 Distance from 200-day average −35.14% 6 Relative strength (6 months) −49.23% 3 1-year return −64.48% 0 Riskvery high98
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 77.2% 100 Volatility (60 days) 184.4% 98 Beta (1 year) 3.02 96
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Hapvida Participacoes e Investimentos is cheaper than similar companies
Hapvida Participacoes e Investimentos's Forward P/E: 4.61, −56% against the median of a group of 10 similar companies (10.4).
Compared with 10 similar companies
| Metric | Hapvida Participacoes e Investimentos | Position in the group | Band |
|---|---|---|---|
| Forward P/E | 4.61 | Low | |
| Operating margin | 5.7% | Low | |
| ROE | -0.4% | Low | |
| Debt/equity | 0.33 | Low | |
| Price/book | 0.06 | Low |
Grey band: the middle half of the group; tick: the median; dot: Hapvida Participacoes e Investimentos. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
R$8.32B
Latest quarter · Q3 2026
Net income
R$101.07M
Latest quarter · Q3 2026
Quarterly net margin
1.2%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- R$2.7B
- EPS
- -R$0.32
- Volume
- 16.26M
- Daily trading
- €9.16M
How Hapvida Participacoes e Investimentos is changing
All resultsRevenue grew 29.8% a year on average over the last 5 years
Operating margin rose from −6.4% to 5.0%
Shares outstanding up 102.6% in 5 years
Returns
Hapvida Participacoes e Investimentos returns with dividends
R$1,000 invested in Hapvida Participacoes e Investimentos 5 years ago, on November 19, 2021, would be worth R$31 today with dividends reinvested: −96.89% in total, −50.04% per year. On price alone it would be R$31 (−96.89%).
| Period | Hapvida Participacoes e Investimentos | Ibovespa | R$1,000 becomes |
|---|---|---|---|
| 1 month | −30.63% | −18.87% | R$694 |
| 6 months | −51.53% | −4.53% | R$485 |
| Year to date | −58.18% | +3.26% | R$418 |
| 1 year | −64.48% | +7.08% | R$355 |
| 3 years | −91.15% | +31.94% | R$89 |
| 5 years | −96.89% | +61.48% | R$31 |
Over the last 6 months it has done better than 0% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. Ibovespa: with dividends. Calculate your investment
The chart in detail
Hapvida Participacoes e Investimentos: technical analysis
Hapvida Participacoes e Investimentos is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 97.7% below its all-time closing high (R$273.00, January 11, 2021).
- Trend
- Downward
- RSI (14 sessions)
- 53
- Between 30 and 70
- vs 200-session average
- −35.14%
Support and resistance
Price areas where Hapvida Participacoes e Investimentos has stopped several times in the last year. They describe the chart; they are not forecasts.
- ResistanceR$10.89+76.73%3 touches, last on July 2, 2026
- ResistanceR$9.88+60.32%5 touches, last on October 21, 2026
- ResistanceR$6.95+12.82%2 touches, last on September 23, 2026
- Last priceR$6.16
- SupportR$6.09−1.08%3 touches, last on September 28, 2026
Volatility and risk
Over the last year it has moved more than the Ibovespa.
- Beta (1 year) vs Ibovespa
- 3.02
- Volatility (60 sessions, annualised)
- 184.4%
- Largest fall in the last year
- −77.15%
Close of November 19, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Hapvida Participacoes e Investimentos: seasonality
Average monthly price change over 9 years
Over the last 9 years, the strongest month for Hapvida Participacoes e Investimentos has been May: +10.68% on average, positive in 7 years out of 9. The weakest has been February: −9.65% on average, positive in 0 years out of 8. November, the current month, has been positive in 3 years out of 8 (−9.57% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +2.95% | +4.95% | 5 of 8 |
| February | −9.65% | −8.92% | 0 of 8 |
| March | −9.38% | −3.86% | 2 of 8 |
| April | +3.24% | +2.35% | 4 of 8 |
| May | +10.68% | +8.50% | 7 of 9 |
| June | −2.94% | −3.69% | 3 of 9 |
| July | +2.89% | +6.01% | 6 of 9 |
| August | +1.59% | +3.44% | 5 of 9 |
| September | −2.15% | −4.00% | 4 of 9 |
| October | −9.00% | −12.00% | 4 of 9 |
| November | −9.57% | −3.26% | 3 of 8 |
| December | +1.56% | +3.15% | 5 of 8 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Hapvida Participacoes e Investimentos and its competitors
Health insurance plans sold through the company's own clinical, outpatient and hospital networks are the offering most people in Brazil associate with Hapvida Participações e Investimentos S.A. The company also sells dental plans through an accredited network, so its customers reach care through both its own facilities and partner providers. Together with its subsidiaries, it operates in the healthcare sector in Brazil, and its activities are concentrated in that country.
- Headquarters
- Fortaleza, Brazil
- Employees
- 66,000
- Founded
- 1979
- Chief executive
- Luccas Adib
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Hapvida Participacoes e InvestimentosHAPV3 | $454.53M | 5.7% | — | −51.53% |
| Inversiones La ConstrucciónILC | $2.2B | 12.1% | 27.2 | +7.41% |
| Hanwha Life Insurance088350 | $2.06B | 9.0% | 3.46 | −33.96% |
| ChallengerCGF | $5.28B | 60.4% | 20.7 | +27.32% |
| Company for Cooperative Insurance8010 | $5.47B | 5.8% | 20.3 | −5.65% |
| Bupa Arabia for Cooperative Insurance8210 | $5.88B | 5.9% | 19.6 | −21.78% |
Same industry or related industries, similar size. Compare Hapvida Participacoes e Investimentos with its competitors · Full profile
More on Hapvida Participacoes e Investimentos
- Hapvida Participacoes e Investimentos revenue and financials
- Hapvida Participacoes e Investimentos valuation
- Hapvida Participacoes e Investimentos stock return
- Hapvida Participacoes e Investimentos employees, headquarters and business
